These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR. Giese T; Engstner M; Mansmann U; Hartschuh W; Arden B J Invest Dermatol; 2005 Mar; 124(3):633-7. PubMed ID: 15737205 [TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Dracopoli NC; Alhadeff B; Houghton AN; Old LJ Cancer Res; 1987 Aug; 47(15):3995-4000. PubMed ID: 2886213 [TBL] [Abstract][Full Text] [Related]
24. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065 [TBL] [Abstract][Full Text] [Related]
25. Biological diversity in metastatic neoplasms: origins and implications. Fidler IJ; Hart IR Science; 1982 Sep; 217(4564):998-1003. PubMed ID: 7112116 [TBL] [Abstract][Full Text] [Related]
26. Gene expression changes in melanoma metastases in response to high-dose chemotherapy during isolated limb perfusion. Wouters J; Stas M; Govaere O; Van den Eynde K; Vankelecom H; van den Oord JJ Pigment Cell Melanoma Res; 2012 Jul; 25(4):454-65. PubMed ID: 22486811 [TBL] [Abstract][Full Text] [Related]
27. Genetic and epigenetic alterations of the APC gene in malignant melanoma. Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491 [TBL] [Abstract][Full Text] [Related]
29. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000 [TBL] [Abstract][Full Text] [Related]
30. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. Demunter A; Stas M; Degreef H; De Wolf-Peeters C; van den Oord JJ J Invest Dermatol; 2001 Dec; 117(6):1483-9. PubMed ID: 11886512 [TBL] [Abstract][Full Text] [Related]
31. The pathogenesis of local recurrence of melanoma at the primary excision site. Heenan PJ; Ghaznawie M Br J Plast Surg; 1999 Apr; 52(3):209-13. PubMed ID: 10474473 [TBL] [Abstract][Full Text] [Related]
36. The natural course of cutaneous melanoma. Leiter U; Meier F; Schittek B; Garbe C J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923 [TBL] [Abstract][Full Text] [Related]
37. Clonal evolution in a primary cutaneous follicle center B cell lymphoma revealed by single cell analysis in sequential biopsies. Golembowski S; Gellrich S; von Zimmermann M; Rutz S; Lippert S; Audring H; Lorenz P; Sterry W; Jahn S Immunobiology; 2000 Apr; 201(5):631-44. PubMed ID: 10834319 [TBL] [Abstract][Full Text] [Related]
38. DNA copy number changes in tumors within the spectrum of cellular, atypical, and metastasizing fibrous histiocytoma. Charli-Joseph Y; Saggini A; Doyle LA; Fletcher CD; Weier J; Mirza S; Vemula S; LeBoit PE J Am Acad Dermatol; 2014 Aug; 71(2):256-63. PubMed ID: 24755122 [TBL] [Abstract][Full Text] [Related]
39. Establishment of human malignant melanoma clonal cell lines that secrete ectopic adrenocorticotropin. Orth DN Nat New Biol; 1973 Mar; 242(114):26-8. PubMed ID: 4348147 [No Abstract] [Full Text] [Related]
40. A new cell line from a recurrent conjunctival melanoma. Keijser S; Maat W; Missotten GS; de Keizer RJ Br J Ophthalmol; 2007 Nov; 91(11):1566-7. PubMed ID: 17947278 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]